SI1963278T1 - Substituirani imidazolinski derivati - Google Patents

Substituirani imidazolinski derivati

Info

Publication number
SI1963278T1
SI1963278T1 SI200630546T SI200630546T SI1963278T1 SI 1963278 T1 SI1963278 T1 SI 1963278T1 SI 200630546 T SI200630546 T SI 200630546T SI 200630546 T SI200630546 T SI 200630546T SI 1963278 T1 SI1963278 T1 SI 1963278T1
Authority
SI
Slovenia
Prior art keywords
alkyl
aryl
saturated
optionally substituted
imidazoline derivatives
Prior art date
Application number
SI200630546T
Other languages
English (en)
Slovenian (sl)
Inventor
Beatrix Merla
Stefan Oberborsch
Bernd Sundermann
Werner Englberger
Hagen-Heinrich Hennies
Heinz Graubaum
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SI1963278T1 publication Critical patent/SI1963278T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200630546T 2005-12-22 2006-12-19 Substituirani imidazolinski derivati SI1963278T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061430A DE102005061430A1 (de) 2005-12-22 2005-12-22 Substituierte Imidazolin-Derivate
EP06841028A EP1963278B1 (de) 2005-12-22 2006-12-19 Substituierte imidazolin-derivate

Publications (1)

Publication Number Publication Date
SI1963278T1 true SI1963278T1 (sl) 2010-03-31

Family

ID=37946192

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630546T SI1963278T1 (sl) 2005-12-22 2006-12-19 Substituirani imidazolinski derivati

Country Status (17)

Country Link
US (1) US7728028B2 (https=)
EP (1) EP1963278B1 (https=)
JP (1) JP2009523124A (https=)
CN (1) CN101384557A (https=)
AT (1) ATE449075T1 (https=)
AU (1) AU2006334743B2 (https=)
CA (1) CA2633918A1 (https=)
CY (1) CY1110465T1 (https=)
DE (2) DE102005061430A1 (https=)
DK (1) DK1963278T3 (https=)
ES (1) ES2336833T3 (https=)
IL (1) IL192268A0 (https=)
PL (1) PL1963278T3 (https=)
PT (1) PT1963278E (https=)
RU (1) RU2427571C2 (https=)
SI (1) SI1963278T1 (https=)
WO (1) WO2007079927A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5599774B2 (ja) 2008-03-27 2014-10-01 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヒドロキシメチルシクロヘキシルアミン類
ATE537143T1 (de) 2008-03-27 2011-12-15 Gruenenthal Gmbh Spiro(5.5)undecan derivate
PT2260042E (pt) 2008-03-27 2011-12-06 Gruenenthal Gmbh Derivados de ciclo-hexano espirocíclicos substituídos
WO2009118174A1 (de) 2008-03-27 2009-10-01 Grünenthal GmbH Substituierte cyclohexyldiamine
CA2719735A1 (en) 2008-03-27 2009-10-01 Gruenenthal Gmbh Substituted 4-aminocyclohexane derivatives
AU2009228637B2 (en) 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2302294A1 (en) * 1997-08-28 1999-03-04 Harlan Edgar Shannon Method for treating pain
US5952360A (en) * 1997-08-28 1999-09-14 Eli Lilly And Company Method for treating neuropathic pain
DE10000312A1 (de) 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
US7183276B2 (en) * 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof
US7345078B2 (en) * 2002-05-31 2008-03-18 The Board Of Trustees Of Michigan State University NF-κB inhibitors and uses thereof
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate

Also Published As

Publication number Publication date
AU2006334743B2 (en) 2011-07-07
JP2009523124A (ja) 2009-06-18
WO2007079927A1 (de) 2007-07-19
ATE449075T1 (de) 2009-12-15
ES2336833T3 (es) 2010-04-16
US7728028B2 (en) 2010-06-01
CN101384557A (zh) 2009-03-11
CA2633918A1 (en) 2007-07-19
PL1963278T3 (pl) 2010-04-30
DE102005061430A1 (de) 2007-07-05
CY1110465T1 (el) 2015-04-29
IL192268A0 (en) 2008-12-29
HK1122019A1 (zh) 2009-05-08
PT1963278E (pt) 2009-12-16
RU2008129377A (ru) 2010-03-27
US20090048323A1 (en) 2009-02-19
EP1963278B1 (de) 2009-11-18
EP1963278A1 (de) 2008-09-03
AU2006334743A1 (en) 2007-07-19
DK1963278T3 (da) 2010-03-29
DE502006005426D1 (de) 2009-12-31
RU2427571C2 (ru) 2011-08-27

Similar Documents

Publication Publication Date Title
SI2010531T1 (sl) Spirociklični cikloheksanski derivati z analgetskim učinkom
CY1110465T1 (el) Υποκατεστημενα παραγωγα ιμιδαζολινης
GEP20084430B (https=)
DE502004005959D1 (de) Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
DK1249450T3 (da) Benzimidazolderivater som human chymase-inhibitorer
ZA200700765B (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
MX2009005925A (es) Compuestos inhibidores de fosfoinositida 3-quinasa y los metodos de uso.
JP2017500321A5 (https=)
EA201270421A1 (ru) 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт
NO20063597L (no) Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
IL192269A0 (en) Substituted oxazole derivatives with an analgesic action
UA98946C2 (en) Phosphoinositide 3-kinase inhibitor compounds and methods of use
ATE341552T1 (de) Derivate morphinähnlicher opioidverbindungen
TW200704633A (en) Process for the preparation of sulfonamide derivatives
DK1828125T3 (da) Arylpiperazinderivater og deres anvendelse som selektive ligander for dopaminets D3 receptor
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
BRPI0514077A (pt) derivados de benzilóxi como inibidores de maob
JP4389271B2 (ja) Ｎ−ヒドロキシホルムアミジン誘導体
HUP0201540A2 (en) Serotomin and 5ht1a receptor antagonist phenoxypropylamine derivatives and use thereof
WO2006123355A3 (en) Novel statin derivatives